Rheumatology Advance Access originally published online on October 1, 2008
Rheumatology 2008 47(12):1838; doi:10.1093/rheumatology/ken375
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Subcutaneous calcification following injection of triamcinolone hexacetonide for plantar fasciitis
1Department of Medicine, Sandwell General Hospital, West Bromwich, 2Department of Plastic Surgery, Selly Oak Hospital, Birmingham and 3Department of Rheumatology, Sandwell General Hospital, West Bromwich, UK
Correspondence to: K. A. Grindulis, Department of Rheumatology, Sandwell General Hospital, West Bromwich B71 4HJ, UK. E-mail: karl.grindulis@swbh.nhs.uk
| The first 10% of the full text of this article appears below. |
SIR, We report a patient who developed subcutaneous calcinosis and ulceration over the heel following injection of triamcinolone hexacetonide. This agent has the potential to cause complications many years after treatment.
A 67-yr-old lady was referred with a weeping ulcer on the medial aspect of the left heel, which had